Literature DB >> 10407014

Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system.

M Sondell1, G Lundborg, M Kanje.   

Abstract

Vascular endothelial growth factor (VEGF) is a mitogen for endothelial cells, and it promotes angiogenesis in vivo. Here we report that VEGF(165) has neurotrophic actions on cultured adult mouse superior cervical ganglia (SCG) and dorsal root ganglia (DRG), measured as axonal outgrowth. Maximal effect was observed at 10-50 ng/ml for SCG and 100 ng/ml for DRG. VEGF-induced axonal outgrowth was inhibited by the mitogen-activated protein kinase kinase inhibitor PD 98059 but not by the protein kinase inhibitor K252a. VEGF also increased survival of both neurons and satellite cells and the number of proliferating Schwann cells. Immunocytochemistry and immunoblotting revealed that VEGF was expressed in virtually all nerve cells in the SCG but only in a population of small-diameter (<35 micrometers) neurons representing approximately 30% of the neurons in DRG. Immunostaining showed that the VEGF receptor fetal liver kinase receptor (flk-1) was found on nerve cell bodies in DRG and to a lesser extent on neurons in SCG. Growth cones of regenerating axons from both types of ganglia exhibited flk-1 immunoreactivity, as did Schwann cells. We conclude that VEGF has both neurotrophic and mitogenic activity on cells in the peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407014      PMCID: PMC6783109     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

1.  Axonal outgrowth and neuronal apoptosis in cultured adult mouse dorsal root ganglion preparations: effects of neurotrophins, of inhibition of neurotrophin actions and of prior axotomy.

Authors:  A Edström; P A Ekström; D Tonge
Journal:  Neuroscience       Date:  1996-12       Impact factor: 3.590

2.  A reciprocal cell-cell interaction mediated by NT-3 and neuregulins controls the early survival and development of sympathetic neuroblasts.

Authors:  J M Verdi; A K Groves; I Fariñas; K Jones; M A Marchionni; L F Reichardt; D J Anderson
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

3.  Effects of delayed re-innervation on the expression of c-erbB receptors by chronically denervated rat Schwann cells in vivo.

Authors:  H Li; G Terenghi; S M Hall
Journal:  Glia       Date:  1997-08       Impact factor: 7.452

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The insulin-like growth factors I and II stimulate proliferation of different types of Schwann cells.

Authors:  M Sondell; A Fex-Svenningsen; M Kanje
Journal:  Neuroreport       Date:  1997-09-08       Impact factor: 1.837

6.  Neurones and glial cells of the mouse sciatic nerve undergo apoptosis after injury in vivo and in vitro.

Authors:  P A Ekström
Journal:  Neuroreport       Date:  1995-05-09       Impact factor: 1.837

7.  A BDNF autocrine loop in adult sensory neurons prevents cell death.

Authors:  A Acheson; J C Conover; J P Fandl; T M DeChiara; M Russell; A Thadani; S P Squinto; G D Yancopoulos; R M Lindsay
Journal:  Nature       Date:  1995-03-30       Impact factor: 49.962

8.  Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues.

Authors:  M Bacic; N A Edwards; M J Merrill
Journal:  Growth Factors       Date:  1995       Impact factor: 2.511

9.  Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells.

Authors:  J B Davis; P Stroobant
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

10.  Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons.

Authors:  S Averill; S B McMahon; D O Clary; L F Reichardt; J V Priestley
Journal:  Eur J Neurosci       Date:  1995-07-01       Impact factor: 3.386

View more
  194 in total

1.  Reversal of experimental diabetic neuropathy by VEGF gene transfer.

Authors:  P Schratzberger; D H Walter; K Rittig; F H Bahlmann; R Pola; C Curry; M Silver; J G Krainin; D H Weinberg; A H Ropper; J M Isner
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury.

Authors:  Laura De Laporte; Anne des Rieux; Hannah M Tuinstra; Marina L Zelivyanskaya; Nora M De Clerck; Andrei A Postnov; Véronique Préat; Lonnie D Shea
Journal:  J Biomed Mater Res A       Date:  2011-05-31       Impact factor: 4.396

3.  CCL20, γδ T cells, and IL-22 in corneal epithelial healing.

Authors:  Zhijie Li; Alan R Burns; Sarah Byeseda Miller; C Wayne Smith
Journal:  FASEB J       Date:  2011-04-25       Impact factor: 5.191

4.  VEGF protein associates to neurons in remote regions following cortical infarct.

Authors:  Ann M Stowe; Erik J Plautz; Ines Eisner-Janowicz; Shawn B Frost; Scott Barbay; Elena V Zoubina; Numa Dancause; Michael D Taylor; Randolph J Nudo
Journal:  J Cereb Blood Flow Metab       Date:  2006-04-26       Impact factor: 6.200

Review 5.  [Tissue engineering of erectile nerves].

Authors:  F May; N Weidner; K Matiasek; M Vroemen; T Mrva; C Caspers; J Henke; T Brill; A Lehmer; A Blesch; W Erhardt; B Gänsbacher; R Hartung
Journal:  Urologe A       Date:  2004-10       Impact factor: 0.639

6.  NK cells modulate the inflammatory response to corneal epithelial abrasion and thereby support wound healing.

Authors:  Qiong Liu; C Wayne Smith; Wanyu Zhang; Alan R Burns; Zhijie Li
Journal:  Am J Pathol       Date:  2012-06-22       Impact factor: 4.307

7.  Cisplatin induced sensory neuropathy is prevented by vascular endothelial growth factor-A.

Authors:  Samanta Vencappa; Lucy F Donaldson; Richard P Hulse
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

8.  Spinal stenosis: assessment of motor function, VEGF expression and angiogenesis in an experimental model in the rat.

Authors:  Kazuyuki Watanabe; Shin-Ichi Konno; Miho Sekiguchi; Shin-Ichi Kikuchi
Journal:  Eur Spine J       Date:  2007-06-02       Impact factor: 3.134

9.  Therapeutic Potential of Pretreatment with Allograft Sertoli Cells Transplantation in Brain Ischemia by Improving Oxidative Defenses.

Authors:  Sara Milanizadeh; Karrar Najm Najaf Zuwarali; Abbas Aliaghaei; Mohammad Reza Bigdeli
Journal:  J Mol Neurosci       Date:  2018-03-17       Impact factor: 3.444

10.  Hyperexcitable neurons and altered non-neuronal cells in the compressed spinal ganglion.

Authors:  Robert H LaMotte; Chao Ma
Journal:  Sheng Li Xue Bao       Date:  2008-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.